Baxter International Inc. · NYSE:BAX
Baxter International — Investor Presentation (October 2021)
15 slides from Baxter International's investor presentation, Oct 18, 2021
Slide 1: Fall Shareholder Engagement
October 2021 Baxter International Inc. Fall Shareholder Engagement
Slide 2: Forward-looking statements
2 This presentation includes forward-looking statements concerning Baxter’s financial results, business development activities, capital structure, cost savings initiatives, R&D pipeline, including results of clinical trials and planned product launches, and outlook for full-year 2021. These forward-
Slide 3: Executive Summary
Executive Summary 3 COVID-19 Response Continued prioritization of the health and safety of Baxter’s 50,000+ employees, and actively supporting patients, clinicians and communities Partnered with Moderna, BioNTech, and Novavax to help manufacture their respective COVID-19 vaccines on a contract b
Slide 4: Baxter: A Leading Medical Products Company
Baxter: A Leading Medical Products Company Established leadership position across portfolio Leadership Optimizing resources across portfolio Global Opportunity Enabling a digital operating model to deliver digital solutions Digital Transformation 2020 Revenue by Business1 Global Category Size & Grow
Slide 5: The Baxter Journey
The Baxter Journey 2016–2017: A Fresh Start 2018–2020: Building the Foundation 2021 and Beyond: Accelerating Transformation Unlocking innovation across the care continuum through digital transformation Intensified focus on entering adjacencies through organic innovation and business development init
Slide 6: Accelerating our Shared Vision to Transform Healthcare
6 Advancing patient care and increasing stakeholder value through expanded reach, high-impact innovation and digital enablement Accelerating our Shared Vision to Transform Healthcare Note: Subject to the approval of Hillrom shareholders and the satisfaction of customary closing conditions (including
Slide 7: Multifaceted Response To The COVID-19 Pandemic
Protecting Employee Health and Safety • Implemented protective measures such as: enhanced infection control actions, remote working arrangements, restricted travel, symptom screening at building entrances, and use of PPE by employees • Modified manufacturing operations to limit interactions between
Slide 8: Extensive Stockholder Engagement Program
Announced Enhancements Informed by our Stockholders ► In response to a stockholder proposal that received majority support at the 2020 Annual Meeting, we conducted extensive engagement with the Company’s stockholders regarding our Board leadership structure ► In November 2020 the Board amended Baxte
Slide 9: Responsiveness to Stockholders
Responsiveness to Stockholders 9 Baxter is committed to being responsive to the views of its stockholders ► Following stockholder approval of a written consent proposal at the 2021 Annual Meeting and extensive engagement efforts, the Board intends to take action to permit stockholders to act by writ
Slide 10: Director Skillsets Support Effective Oversight Of Strategy
Other Sector Leadership Diversity 8 Director Skillsets Support Effective Oversight Of Strategy CC = Compensation Committee; AC = Audit Committee; NCGPP = Nominating, Corporate Governance & Public Policy Committee; QCT = Quality, Compliance & Technology Committee; asterisk denotes committee chair. 1
Slide 11: Executive Compensation Aligned With Strategic Priorities
Executive Compensation Aligned With Strategic Priorities 11 CEO Target Pay Mix (2020) 9% 15% 38% 38% Salary Target Cash Bonus Target Stock Options Target PSUs 91% Variable/ “At-Risk” A significant majority of executive pay is “at risk” and only delivered if specific annual and long-term performance
Slide 12: Executive Compensation Program Changes and Practices
Executive Compensation Program Changes and Practices 12 Baxter continues to evolve its executive compensation program based on the Company’s operational strategy and stockholder feedback Compensation Practices ► Pay-for-performance alignment ► Clawback policy ► Stock ownership guidelines for executi
Slide 13: Demonstrating Leadership In Corporate Social Responsibility
Demonstrating Leadership In Corporate Social Responsibility Baxter 2015 – 2020 Corporate Responsibility Priorities and Goals Meaningful Progress and Milestones Achieved WORKPLACE CULTURE Promote inclusion, diversity and employee engagement ETHICS AND COMPLIANCE Drive a culture of integrity and the h
Slide 14: 2030 Corporate Responsibility Commitment and Goals
2030 Corporate Responsibility Commitment and Goals 14
Slide 15: A Recognized Top Employer And Outstanding Corporate Citizen
A Recognized Top Employer And Outstanding Corporate Citizen 15 Recent Highlights Focusing On Inclusion and Diversity Expanding Access To Care Serving Our Communities Worldwide Reducing Our Environmental Footprint For more information on Baxter’s efforts to benefit our communities, employees, and sta
Baxter International — Investor Presentation (October 2021) on 6ix